DBI-002 / DermBiont - LARVOL DELTA

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis (clinicaltrials.gov) - P2 | N=24 | Active, not recruiting | Sponsor: DermBiont, Inc. | Trial completion date: Dec 2022 ➔ Dec 2023 | Trial primary completion date: Oct 2022 ➔ Dec 2023

Trial completion date • Trial primary completion date • Dermatology

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis (clinicaltrials.gov) - P2 | N=60 | Suspended | Sponsor: DermBiont, Inc. | Initiation date: Oct 2022 ➔ Mar 2023

Trial initiation date • Infectious Disease

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis (clinicaltrials.gov) - P2 | N=24 | Active, not recruiting | Sponsor: DermBiont, Inc. | Recruiting ➔ Active, not recruiting

Enrollment closed • Dermatology

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis (clinicaltrials.gov) - P2 | N=60 | Suspended | Sponsor: DermBiont, Inc. | Recruiting ➔ Suspended

Trial suspension • Infectious Disease

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis (clinicaltrials.gov) - P2 | N=24 | Recruiting | Sponsor: DermBiont, Inc.

New P2 trial • Dermatology

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis (clinicaltrials.gov) - P2 | N=60 | Recruiting | Sponsor: DermBiont, Inc.

New P2 trial • Infectious Disease

A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor (clinicaltrials.gov) - P2; N=34; Completed; Sponsor: DermBiont, Inc.; Active, not recruiting ➔ Completed

Clinical • Trial completion • Dermatology